Tag: pirtobrutinib

Illustration of triple-drug therapy combination for chronic lymphocytic leukemia treatment
Clinical UpdatesNew StudiesPracticeResearch Digest

Adding pirtobrutinib to venetoclax-rituximab improves survival in relapsed chronic lymphocytic leukemia

Adding the BTK inhibitor pirtobrutinib to venetoclax-rituximab significantly improves progression-free survival in patients with relapsed or refractory chronic lymphocytic leukemia,…

By
GMJ Practice Desk

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →
Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network